|
OTC asthma inhaler endangers patients by encouraging substandard treatment
News-Medical.net An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit … Seasons change, so do asthma triggers |
View full post on asthma – Google News